Jonas Jarvius

(Mr. Jonas Jarvius)

Currently holds positions in Q Linea AB and QuiaPEG Pharmaceuticals Holding AB

Positions

Position Company Period
Chief Executive Officer Q Linea AB Jan. 1, 2008 -
Director QuiaPEG Pharmaceuticals Holding AB March 29, 2017 -
Jonas Jarvius's trades of Q Linea AB's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
2
10.16
SEK 2 		2 10.16 SEK 20
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
300
10.32
SEK 298 		300 10.32 SEK 3,096
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
3,047
10.34
SEK 3,031 		3,047 10.34 SEK 31,506
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
5
10.40
SEK 5 		5 10.40 SEK 52
2023-03-01 2023-02-28
SE Q Linea AB (QLINEA)
B Purchase
41,646
10.50
SEK 42,067 		41,646 10.50 SEK 437,283
2022-03-08 2022-03-08
SE Q Linea AB (QLINEA)
B Purchase
6,000
79.95
SEK 49,358 		6,000 79.95 SEK 479,700
2021-06-11 2021-06-10
SE Q Linea AB (QLINEA)
S Sale
95,000
145.40
SEK 1,421,266 		95,000 145.40 SEK 13,813,000
// ... existing code ... // ... rest of the file ...